Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing compound doai
Reexamination Certificate
2011-06-14
2011-06-14
Kim, Jennifer M (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing compound doai
Reexamination Certificate
active
07960438
ABSTRACT:
The present invention relates to the use of agomelatine, or N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide, in obtaining medicaments intended for the treatment of Generalized Anxiety Disorder.
REFERENCES:
patent: 5194614 (1993-03-01), Andrieux et al.
patent: 5225442 (1993-07-01), Andrieux et al.
patent: 5318994 (1994-06-01), Andrieux et al.
patent: 7250531 (2007-07-01), Souvie et al.
patent: 7358395 (2008-04-01), Coquerel et al.
patent: 2005/0164987 (2005-07-01), Barberich
patent: 2006/0205754 (2006-09-01), Willigers
patent: 2006/0270876 (2006-11-01), Coquerel et al.
patent: 2007/0185080 (2007-08-01), Eriksson et al.
patent: 0447285 (1991-09-01), None
patent: 1564202 (2005-08-01), None
patent: 2005/002562 (2005-01-01), None
patent: 2006/096434 (2006-09-01), None
Servier Labortories (FR) Agomelatine S-20098, Drugs of the Future 2003, 28(1): 7-13.
E. Mocaer, et al., “Development of 1-4 a new antidepressant: agomelatine” Medecine Sciences, vol. 21, No. 10, Oct. 2005.
S.A. Montgomery, et al., “Absence of discontinuation symptoms with agomelatine and occurrence of discountinuation symptoms with paroxetine: a randomized double-blind, placebo-controlled discontinuation study” International Clinical Psychopharmacology, vol. 19, No. 5, Sep. 2004.
French Preliminary Search Report for FR06/03083 of Nov. 21, 2006.
Diagnostic Criteria for Generalized Anxiety Disorder,Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, 2000.
Delalleau Bruno
Fabiano Agnes
Millan Mark
Mocaer Elisabeth
Hueschen and Sage
Kim Jennifer M
Les Laboratoires Servier
LandOfFree
Use of agomelatine in obtaining medicaments intended for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of agomelatine in obtaining medicaments intended for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of agomelatine in obtaining medicaments intended for the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2744637